(Q34453945)

2 August 2017

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward (English)

1 reference

2 August 2017

L J Herberg

1

1 reference

PubMed ID

2550989

2 August 2017

I C Rose

series ordinal

2

1 reference

2 August 2017

1 January 1989

1 reference

2 August 2017

1 reference

2 August 2017

99

1 reference

2 August 2017

87-90

1 reference

2 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00634458

2 August 2017

0 references

cites work

The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain

1 reference

12 December 2020

Learning and memory: regional changes in N-methyl-D-aspartate receptors in the chick brain after imprinting

1 reference

12 December 2020

Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex

1 reference

12 December 2020

Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens.

1 reference

12 December 2020

Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys

1 reference

12 December 2020

Neurotransmitter glutamate: its clinical importance.

1 reference

12 December 2020

Learning impairment in rats by N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

Catecholamine release within the striatum of the freely moving rat.

1 reference

12 December 2020

Elevated levels of amino acids in the CSF of motor neuron disease patients

1 reference

12 December 2020

Anti-conflict and depressant effects by GABA agonists and antagonists, benzodiazepines and non-gabergic anticonvulsants on self-stimulation and locomotor activity

1 reference

12 December 2020

Amnesic effect of the novel anticonvulsant MK-801.

1 reference

12 December 2020

Catecholamines and self-stimulation: Evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine

1 reference

12 December 2020

Chronic l-dopa fails to lessen rebound enhancement of self-stimulation after chronic haloperidol

1 reference

12 December 2020

Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders.

1 reference

12 December 2020

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

1 reference

12 December 2020

ANTICONVULSANT DRUGS AND SELF-STIMULATING BEHAVIOR.

1 reference

12 December 2020

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

12 December 2020

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

12 December 2020

Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine.

1 reference

12 December 2020

Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology

1 reference

12 December 2020

Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord

1 reference

12 December 2020

The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens

1 reference

12 December 2020

Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models

1 reference

12 December 2020

Zinc, glutamate receptors, and motoneurone disease

1 reference

12 December 2020

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 reference

12 December 2020

Quinolinic acid and other kynurenines in the central nervous system

1 reference

12 December 2020

Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain

1 reference

12 December 2020

Action of drugs of abuse on brain reward systems: an update with specific attention to opiates.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00634458

1 reference

PubMed ID

2550989

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

2550989